Clinical Trial Update: The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial exploring the relationship between homocysteine levels and contrast-induced nephropathy in hypertensive patients undergoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Disease
• Hypertension
• Nephropathy

Snippet

Sponsor: Fuling Central Hospital of Chongqing City | Conditions: Homocysteine, Coronary Disease | Phase 2, Phase 3 | Status: COMPLETED